Accelerating global access to life-saving vaccines.

We apply rigorous science to build knowledge and support for the value of vaccines.

3 Things We Know About Vaccines in a Climate Change Future
September 2019

By Molly Sauer Climate change ranks among the WHO’s top 10 threats for 2019—a dubious honor indicating not only its potential effects on human health and vulnerable populations, but also the urgent need for a dedicated global effort to understand and mitigate its impact. How will vaccine-preventable diseases be affected by climate change, and what […]

Read More >
Four takeaways from iHEA 2019, a Swiss summit on health economics
August 2019

Last month, representatives from the IVAC Economics and Finance (E&F) team attended the International Health Economics Association (iHEA) Congress in Basel, Switzerland. As new members of Immunization Economics, a specialized group of economists working on immunization, Bryan Patenaude, Cristina Garcia, Gatien de Broucker, and Elizabeth (Libby) Watts had several significant contributions to the biannual conference. […]

Read More >
IVAC-led PERCH study reveals viruses as new leading cause of global childhood pneumonia
June 2019

Respiratory syncytial virus (RSV) and other viruses now appear to be the main causes of severe childhood pneumonia in low- and middle-income countries, highlighting the need for vaccines against these pathogens, according to a study from a consortium of scientists from around the world led by the International Vaccine Access Center in the Johns Hopkins Bloomberg School of Public Health.

Read More >
Digital Tools

IVAC’s digital platforms contain downloadable vaccine introduction maps, messaging compendiums, advocacy guides, and more.

Where We Work

IVAC works with governments and major research institutions in 38 countries

[Where We Work - Map]